During the past decade, North Carolina Cancer Hospital conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 5 clinical trials were completed, i.e. on average, 62.5% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "North Carolina Cancer Hospital" #1 collaborator was "Pfizer" with 2 trials as a collaborator, "GlaxoSmithKline" with 1 trials as a collaborator and "Merck Sharp & Dohme LLC" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "North Carolina Cancer Hospital" are "Bladder Cancer" (2 trials), "Breast Cancer" (2 trials), "Amyloidosis" (1 trials), "Cancer" (1 trials) and "Castleman's Disease" (1 trials). Many other conditions were trialed in "North Carolina Cancer Hospital" in a lesser frequency.

Most popular intervention types in "North Carolina Cancer Hospital" are "Drug" (6 trials), "Behavioral" (2 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "16-week Exercise Rehabilitation Program for Breast Cancer Survivors" (1 trials), "AYA NA-SB Questionnaire" (1 trials), "Abatacept" (1 trials), "Acetaminophen" (1 trials) and "Alemtuzumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "North Carolina Cancer Hospital" are 8 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "North Carolina Cancer Hospital". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in North Carolina Cancer Hospital, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in North Carolina Cancer Hospital, 1 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".